Our Pricing

Promethazine BNF: Benefits and Uses Explained

Published on: June 03, 2026

Understanding promethazine BNF UK pharmacy guidance is essential for safe, effective use of this versatile antihistamine. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar and clinical team provide expert guidance on promethazine hydrochloride for allergic conditions, nausea, and short-term sleep disturbances, with transparent pricing from £17.54.

What Is Promethazine and How Does It Work?

Promethazine hydrochloride is a first-generation antihistamine with sedative, antiemetic, and anticholinergic properties licensed by the MHRA for use in the UK [1]. As a phenothiazine derivative, it works by blocking histamine H1 receptors throughout the body, preventing the allergic cascade that causes symptoms like itching, sneezing, and urticaria.

Unlike newer non-sedating antihistamines such as cetirizine or loratadine, promethazine crosses the blood-brain barrier readily, producing central nervous system effects that make it particularly useful for short-term insomnia and motion sickness [1][2]. The British National Formulary (BNF) lists promethazine under multiple therapeutic categories, reflecting its broad clinical utility in UK practice.

The medication's antiemetic action results from antagonism at dopamine D2 receptors in the chemoreceptor trigger zone, whilst its anticholinergic effects contribute to both therapeutic benefits and potential side effects [2]. This multi-receptor activity explains why promethazine remains a valuable option despite the availability of more selective alternatives.

BNF-Listed Indications for Promethazine

The British National Formulary recognises three primary indications for promethazine hydrochloride in UK clinical practice. For allergic conditions, promethazine provides effective relief from urticaria, pruritus, allergic rhinitis, and insect bites, typically at doses of 10-20mg two to three times daily [3]. The sedative properties make it particularly suitable for allergic conditions that disturb sleep.

As an antiemetic, promethazine is indicated for nausea and vomiting associated with motion sickness, vertigo, and labyrinthine disorders. For motion sickness prevention, the BNF recommends taking 20-25mg the night before travel, followed by a repeat dose 1-2 hours before departure if needed [3]. This prophylactic approach leverages promethazine's long duration of action, which extends 6-12 hours.

For short-term insomnia in adults, promethazine 20-50mg at bedtime offers a non-benzodiazepine option when occasional sleep aid is required [3]. The BNF emphasises this should be short-term use only, as tolerance to sedative effects develops within days to weeks of continuous administration.

Paediatric Indications and Age Restrictions

The BNF provides specific age-related guidance for promethazine use in children. Phenergan tablets and elixir are licensed for children aged 5 years and over for allergic conditions, with doses adjusted by age and body weight [3]. For children aged 5-10 years, typical doses range from 5-15mg daily, whilst those over 10 years may receive adult doses subject to prescriber assessment.

Importantly, promethazine is contraindicated in children under 2 years due to the risk of fatal respiratory depression, and the MHRA has issued specific warnings about over-the-counter use in children under 6 years [4]. Any use in children requires careful prescriber evaluation of the risk-benefit profile.

Promethazine Formulations Available at Cured Pharmacy

Cured Pharmacy stocks three promethazine hydrochloride formulations to meet different clinical needs. Phenergan 25mg Tablets provide the standard oral dose for adults, available from £17.54 for 56 tablets. This formulation suits patients requiring regular dosing for allergic conditions or those who prefer solid oral forms.

Phenergan Elixir offers a liquid alternative containing 5mg promethazine hydrochloride per 5ml, priced from £17.54. The elixir formulation is particularly valuable for patients who struggle with tablet swallowing, require precise dose titration, or need paediatric dosing flexibility. The pleasant-tasting syrup improves compliance in younger patients aged 5 years and over.

Phenergan Night Tablets 25mg, available from £17.54, are specifically marketed for short-term sleep disturbances. Whilst the active ingredient and dose are identical to standard Phenergan 25mg tablets, this pack size and presentation target occasional insomnia rather than chronic allergic conditions, helping patients select the appropriate product for their needs.

Choosing the Right Formulation

Your choice of formulation should align with your specific indication and practical needs. Tablets offer convenience and precise dosing for adults, whilst the elixir provides flexibility for children over 5 years or adults requiring doses between 5-20mg. All promethazine products require clinical assessment by a UK prescriber before dispensing, ensuring appropriate selection based on your medical history and concurrent medications.

Clinical Evidence and Efficacy Data

Promethazine's efficacy in allergic conditions is well-established through decades of clinical use, though modern randomised controlled trials are limited compared to newer antihistamines. Systematic reviews demonstrate that first-generation antihistamines including promethazine effectively reduce allergic symptoms, with sedative effects providing additional benefit when pruritus disturbs sleep [5].

For motion sickness prevention, promethazine shows superior efficacy compared to placebo, with studies demonstrating significant reduction in nausea and vomiting during provocative motion stimuli [6]. The antiemetic effect begins within 20 minutes of oral administration and persists for 6-12 hours, making single-dose prophylaxis practical for most journeys.

As a hypnotic agent, promethazine reduces sleep latency and increases total sleep time in short-term studies, though tolerance develops rapidly with continued use [7]. Polysomnographic data shows promethazine suppresses REM sleep and alters sleep architecture, which limits its suitability for chronic insomnia management. The BNF's restriction to short-term use reflects this pharmacological profile.

Dosing Guidance and Administration

For allergic conditions in adults, the typical promethazine dose is 10-20mg two to three times daily, or 25mg at bedtime when symptoms are predominantly nocturnal [3]. Some patients may require up to 25mg three times daily, though this higher dosing increases sedation and anticholinergic effects. Doses should be taken with or after food to minimise gastrointestinal upset.

When using promethazine for motion sickness prevention, take 20-25mg the evening before travel, then repeat the dose 1-2 hours before departure if the journey is prolonged [3]. For established motion sickness, 25mg should be taken as soon as symptoms begin, with further doses every 4-6 hours as needed, not exceeding 100mg daily.

For short-term insomnia, adults should take 20-50mg at bedtime, selecting the lowest effective dose [3]. Elderly patients often require dose reduction to 10-20mg due to increased sensitivity to anticholinergic and sedative effects. Promethazine should not be used for insomnia beyond 7-10 consecutive nights without prescriber review, as tolerance develops and underlying sleep disorders may require alternative management.

Special Populations and Dose Adjustments

Patients with hepatic impairment may require dose reduction, as promethazine undergoes extensive hepatic metabolism. Renal impairment does not typically necessitate dose adjustment, though caution is advised in severe renal disease. Elderly patients are more susceptible to anticholinergic side effects including confusion, urinary retention, and falls, warranting conservative initial dosing and careful monitoring [3].

Side Effects, Contraindications, and Safety Considerations

The most common side effects of promethazine relate to its sedative and anticholinergic properties. Drowsiness affects the majority of users, particularly during initial treatment, and patients must be warned against driving or operating machinery until they know how promethazine affects them [3]. Other frequent anticholinergic effects include dry mouth, blurred vision, urinary retention, and constipation.

Paradoxical stimulation can occur, particularly in children and elderly patients, manifesting as restlessness, excitability, or nightmares rather than sedation [3]. This unpredictable response necessitates careful monitoring when initiating treatment in vulnerable populations. Extrapyramidal effects, though rare with promethazine compared to other phenothiazines, may include dystonic reactions and akathisia.

Promethazine is contraindicated in several clinical scenarios outlined in the BNF. These include children under 2 years (due to respiratory depression risk), comatose states, patients receiving monoamine oxidase inhibitors, and those with severe coronary artery disease or narrow-angle glaucoma [3][4]. Caution is required in epilepsy, as promethazine may lower seizure threshold, and in prostatic hypertrophy, where anticholinergic effects may precipitate urinary retention.

Drug Interactions and Concurrent Medications

Promethazine potentiates the sedative effects of alcohol, benzodiazepines, opioids, and other central nervous system depressants, creating risk of excessive sedation and respiratory depression [3]. Concurrent use with anticholinergic medications (including tricyclic antidepressants, antimuscarinics for urinary symptoms, and some antiparkinsonian drugs) may produce additive anticholinergic effects. Your UK prescriber will review your medication list during consultation to identify potential interactions before approving promethazine treatment.

Scientific References

1. Simons, F. E. R. (2004). Advances in H1-antihistamines. New England Journal of Medicine, 351(21), 2203–2217. https://doi.org/10.1056/NEJMra033121 [accessed 13 August 2026]
2. Tietjen, G. E., & Khubchandani, J. (2009). Antihistamines in the treatment of migraine. CNS Drugs, 23(7), 569–579. https://doi.org/10.2165/00023210-200923070-00002 [accessed 13 August 2026]
3. Joint Formulary Committee. (2024). British National Formulary (87th ed.). London: BMJ Group and Pharmaceutical Press. [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2019). Over-the-counter cough and cold medicines for children: MHRA review confirms restrictions. Drug Safety Update, 12(8), 1–3. [accessed 13 August 2026]
5. Church, M. K., & Church, D. S. (2013). Pharmacology of antihistamines. Indian Journal of Dermatology, 58(3), 219–224. https://doi.org/10.4103/0019-5154.110832 [accessed 13 August 2026]
6. Spinks, A., & Wasiak, J. (2011). Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database of Systematic Reviews, (6), CD002851. https://doi.org/10.1002/14651858.CD002851.pub4 [accessed 13 August 2026]
7. Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019). The assessment and management of insomnia: an update. World Psychiatry, 18(3), 337–352. https://doi.org/10.1002/wps.20674 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.